Randomized Trial: A Head-to-head Comparison of the Efficacy and Safety of Ixekizumab and Adalimumab in Biological-naïve Patients with Active Psoriatic Arthritis
14 Jan, 2020 | 00:02h | UTCCommentary: We Have a Winner: Head-to-Head Study Compares Biologics for PsA – MedPage Today (free registration required)